An Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta

NCT00982124 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Osteogenesis Imperfecta

Interventions

DRUG: Zoledronic Acid

Sponsor

Shriners Hospitals for Children

Collaborators

[object Object]